Cart
sales@molnova.com
Dimethylaminomicheliolide HCl
CAS No. 1403357-80-1
Dimethylaminomicheliolide HCl( —— )
Catalog No. M35324 CAS No. 1403357-80-1
Dimethylaminomicheliolide HCl has potential anti-inflammatory and anti-tumor activity and inhibits the proliferation of glioblastoma cells by targeting pyruvate kinase 2 (PKM2) and reconnecting aerobic cell populations.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 459 | In Stock |
|
| 10MG | 657 | In Stock |
|
| 25MG | 1026 | In Stock |
|
| 50MG | 1386 | In Stock |
|
| 100MG | 1832 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDimethylaminomicheliolide HCl
-
NoteResearch use only, not for human use.
-
Brief DescriptionDimethylaminomicheliolide HCl has potential anti-inflammatory and anti-tumor activity and inhibits the proliferation of glioblastoma cells by targeting pyruvate kinase 2 (PKM2) and reconnecting aerobic cell populations.
-
DescriptionDimethylaminomicheliolide HCl has potential anti-inflammatory and anti-tumor activity and inhibits the proliferation of glioblastoma cells by targeting pyruvate kinase 2 (PKM2) and reconnecting aerobic cell populations.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorPKM
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1403357-80-1
-
Formula Weight329.86
-
Molecular FormulaC17H28ClNO3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC[C@]1(O)[C@@]2([C@@]3([C@]([C@H](CN(C)C)C(=O)O3)(CCC(C)=C2CC1)[H])[H])[H].Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Relacorilant
Relacorilant is a selective and orally bioavailable antagonist of glucocorticoid receptor.
-
Grandifloroside
Grandifloroside shows good antioxidative and potent anti-inflammatory activities, it also exhibits potent inhibitory activity against TNF-α and 5α-reductase, suggests that it might be developed as a source of potent anti-oxidative and anti-inflammatory agents and therapeutic agent for benign prostatic hypertrophy (BPH).
-
4A/4B, Peptide (1)
4A/4B, Peptide (1)
